Webcast

Prescient Therapeutics Investor Briefing – 4 August

August 4, 2020

Prescient Therapeutics Investor Briefing – 4 August

Prescient Therapeutics (ASX: PTX) Webcast Replay

Steven Yatomi-Clarke, CEO & MD of Prescient Therapeutics (ASX:PTX) provides an update on the company’s next-gen CAR-T asset enhanced cell therapy capabilities – maybe the most promising global frontier in the fight against cancer – as well as their other cancer therapy programs.

Recorded on 4 August 2020 at 12pm (AEST).

Join the next Prescient Therapeutics webcast

Speak to our Advisor team about this company

FEATURE SPEAKERS

PATRICK NELSON

Chief Executive Officer - Reach Markets

STEVEN YATOMI-CLARKE

Chief Executive Officer & Managing Director - Prescient Therapeutics

Speak to our Advisor team about this company



By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.